Category: Oncology/Hematology
Oncology/Hematology market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Melanoma Therapeutics
The 2025-2030 World Outlook for Melanoma Therapeutics This study covers the world outlook for melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Disease-Specific Chronic Myelogenous Leukemia Treatments
The 2025-2030 World Outlook for Disease-Specific Chronic Myelogenous Leukemia Treatments This study covers the world outlook for disease-specific chronic myelogenous leukemia treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential in ... Read More
-
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics This study covers the world outlook for non-small cell lung cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the ... Read More
-
The 2025-2030 World Outlook for Oncology Molecular Diagnostics
The 2025-2030 World Outlook for Oncology Molecular Diagnostics This study covers the world outlook for oncology molecular diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Liver Cancer Diagnostics
The 2025-2030 World Outlook for Liver Cancer Diagnostics This study covers the world outlook for liver cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Melanoma Scanners
The 2025-2030 World Outlook for Melanoma Scanners This study covers the world outlook for melanoma scanners across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Thyroid Cancer Drugs
The 2025-2030 World Outlook for Thyroid Cancer Drugs This study covers the world outlook for thyroid cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Multiple Myeloma Therapeutics
The 2025-2030 World Outlook for Multiple Myeloma Therapeutics This study covers the world outlook for multiple myeloma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Triple-Negative Breast Cancer Treatments
The 2025-2030 World Outlook for Triple-Negative Breast Cancer Treatments This study covers the world outlook for triple-negative breast cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Therapeutics
The 2025-2030 World Outlook for Colorectal Cancer Therapeutics This study covers the world outlook for colorectal cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Oncology Nutrition
The 2025-2030 World Outlook for Oncology Nutrition This study covers the world outlook for oncology nutrition across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Therapies and Diagnostics for Ovarian Cancers
The 2025-2030 World Outlook for Therapies and Diagnostics for Ovarian Cancers This study covers the world outlook for therapies and diagnostics for ovarian cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Neuroendocrine Carcinoma
The 2025-2030 World Outlook for Neuroendocrine Carcinoma This study covers the world outlook for neuroendocrine carcinoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Immunotherapy Cancer Drugs
The 2025-2030 World Outlook for Immunotherapy Cancer Drugs This study covers the world outlook for immunotherapy cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Kidney Cancer Drugs
The 2025-2030 World Outlook for Kidney Cancer Drugs This study covers the world outlook for kidney cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Hematological Cancer Treatments
The 2025-2030 World Outlook for Hematological Cancer Treatments This study covers the world outlook for hematological cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Cutaneous Melanoma Therapeutics
The 2025-2030 World Outlook for Cutaneous Melanoma Therapeutics This study covers the world outlook for cutaneous melanoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Veterinary Hematology Table Top Analyzers
The 2025-2030 World Outlook for Veterinary Hematology Table Top Analyzers This study covers the world outlook for veterinary hematology table top analyzers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Head and Neck Oncology Nutrition
The 2025-2030 World Outlook for Head and Neck Oncology Nutrition This study covers the world outlook for head and neck oncology nutrition across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Cancer Biomarkers
The 2025-2030 World Outlook for Cancer Biomarkers This study covers the world outlook for cancer biomarkers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Cancer Immunotherapy Drug Discovery Outsourcing
The 2025-2030 World Outlook for Cancer Immunotherapy Drug Discovery Outsourcing This study covers the world outlook for cancer immunotherapy drug discovery outsourcing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Pancreatic Cancer Treatments
The 2025-2030 World Outlook for Pancreatic Cancer Treatments This study covers the world outlook for pancreatic cancer treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Pancreatic Cancers
The 2025-2030 World Outlook for Pancreatic Cancers This study covers the world outlook for pancreatic cancers across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Squamous Cell Carcinoma of the Head and Neck Treatments
The 2025-2030 World Outlook for Squamous Cell Carcinoma of the Head and Neck Treatments This study covers the world outlook for squamous cell carcinoma of the head and neck treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy
The 2025-2030 World Outlook for HER-2 Positive Breast Cancer Chemotherapy This study covers the world outlook for HER-2 positive breast cancer chemotherapy across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
Research Assistance
